Recent QTRX News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:15:48 PM
- Quanterix Releases Financial Results for the First Quarter of 2024 • Business Wire • 05/07/2024 08:00:00 PM
- Quanterix To Report First Quarter 2024 Financial Results • Business Wire • 04/29/2024 08:00:00 PM
- Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure • Business Wire • 03/21/2024 09:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/04/2024 10:27:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:09:05 PM
- Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease • Business Wire • 03/04/2024 02:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 09:58:13 PM
- Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023 • Business Wire • 02/29/2024 09:00:00 PM
- Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance • Business Wire • 02/26/2024 11:58:00 PM
- Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s Disease • Business Wire • 02/26/2024 02:00:00 PM
- Quanterix to Present at Cowen’s 44th Annual Health Care Conference • Business Wire • 02/23/2024 09:30:00 PM
- Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call • Business Wire • 02/16/2024 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:52:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:57:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 09:07:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 09:07:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 09:52:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:05:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:09:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:09:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:02:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/02/2024 10:21:34 PM
- Quanterix to Present at 42nd Annual J.P. Morgan Healthcare Conference • Business Wire • 12/12/2023 09:00:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM